Cost-effectiveness of physical activity in the management of COPD patients in the UK

Mafalda Ramos,1 Mark Lamotte,1 Laetitia Gerlier,1 Per Svangren,2 Anna Miquel-Cases,3 John Haughney4 1Real World Evidence Solutions, IQVIA, 1930 Zaventem, Belgium; 2Core Respiratory, Global Product and Portfolio Strategy – Global Payer Evidence and Pricing, AstraZeneca Gothenburg R&amp...

Full description

Bibliographic Details
Main Authors: Ramos M, Lamotte M, Gerlier L, Svangren P, Miquel-Cases A, Haughney J
Format: Article
Language:English
Published: Dove Medical Press 2019-01-01
Series:International Journal of COPD
Subjects:
Online Access:https://www.dovepress.com/cost-effectiveness-of-physical-activity-in-the-management-of-copd-pati-peer-reviewed-article-COPD
_version_ 1819163794692112384
author Ramos M
Lamotte M
Gerlier L
Svangren P
Miquel-Cases A
Haughney J
author_facet Ramos M
Lamotte M
Gerlier L
Svangren P
Miquel-Cases A
Haughney J
author_sort Ramos M
collection DOAJ
description Mafalda Ramos,1 Mark Lamotte,1 Laetitia Gerlier,1 Per Svangren,2 Anna Miquel-Cases,3 John Haughney4 1Real World Evidence Solutions, IQVIA, 1930 Zaventem, Belgium; 2Core Respiratory, Global Product and Portfolio Strategy – Global Payer Evidence and Pricing, AstraZeneca Gothenburg R&D, SE-431 83 Mölndal, Sweden; 3Global Price and Reimbursement, Global Payer Evidence and Pricing, AstraZeneca Gothenburg R&D, Cambridge CB2 8PA, UK; 4Academic Primary Care Division of Applied Health Sciences, University of Aberdeen, Aberdeen AB25 2ZD, UK Background: While the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines advise exercise to reduce disease progression, little investment in promoting physical activity (PA) is made by health care authorities. The purpose of this study was to estimate the cost-effectiveness of regular PA vs sedentary lifestyle in people with COPD in the UK.Methods: Efficacy, quality of life, and economic evidence on the PA effects in COPD patients were retrieved from literature to serve as input for a Markov microsimulation model comparing a COPD population performing PA vs a COPD population with sedentary lifestyle. The GOLD classification defined the model health states. For the base case, the cost of PA was estimated at zero, a lifetime horizon was used, and costs and effects were discounted at 3.5%. Analyses were performed from the UK National Health Service (NHS) perspective. Uncertainty around inputs and assumptions were explored via scenario and sensitivity analyses, including a cost threshold analysis. Outcomes were cost/quality-adjusted life year (QALY) gained and cost/year gained.Results: Based on our model, the effects of PA in the UK COPD population would be lower mortality (-6%), fewer hospitalizations (-2%), gains in years (+0.82) and QALYs (+0.66), and total cost savings of £2,568. The cost/QALY and cost/year gained were dominant. PA was cost-saving at costs <£35/month and cost-effective at cost <£202/month. The main model drivers were age and PA impact on death and hospital-treated exacerbations.Conclusion: Including PA in the management of COPD leads to long-term clinical benefits. If the NHS promotes only exercise via medical advice, this would lead to health care cost savings. If the NHS chose to fund PA, it would still likely be cost-effective. Keywords: cost-effectiveness, physical activity, exercise, COPD, microsimulation, Markov 
first_indexed 2024-12-22T17:49:48Z
format Article
id doaj.art-d41c9678f96740a29480b69e56e4032f
institution Directory Open Access Journal
issn 1178-2005
language English
last_indexed 2024-12-22T17:49:48Z
publishDate 2019-01-01
publisher Dove Medical Press
record_format Article
series International Journal of COPD
spelling doaj.art-d41c9678f96740a29480b69e56e4032f2022-12-21T18:18:13ZengDove Medical PressInternational Journal of COPD1178-20052019-01-01Volume 1422723943607Cost-effectiveness of physical activity in the management of COPD patients in the UKRamos MLamotte MGerlier LSvangren PMiquel-Cases AHaughney JMafalda Ramos,1 Mark Lamotte,1 Laetitia Gerlier,1 Per Svangren,2 Anna Miquel-Cases,3 John Haughney4 1Real World Evidence Solutions, IQVIA, 1930 Zaventem, Belgium; 2Core Respiratory, Global Product and Portfolio Strategy – Global Payer Evidence and Pricing, AstraZeneca Gothenburg R&D, SE-431 83 Mölndal, Sweden; 3Global Price and Reimbursement, Global Payer Evidence and Pricing, AstraZeneca Gothenburg R&D, Cambridge CB2 8PA, UK; 4Academic Primary Care Division of Applied Health Sciences, University of Aberdeen, Aberdeen AB25 2ZD, UK Background: While the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines advise exercise to reduce disease progression, little investment in promoting physical activity (PA) is made by health care authorities. The purpose of this study was to estimate the cost-effectiveness of regular PA vs sedentary lifestyle in people with COPD in the UK.Methods: Efficacy, quality of life, and economic evidence on the PA effects in COPD patients were retrieved from literature to serve as input for a Markov microsimulation model comparing a COPD population performing PA vs a COPD population with sedentary lifestyle. The GOLD classification defined the model health states. For the base case, the cost of PA was estimated at zero, a lifetime horizon was used, and costs and effects were discounted at 3.5%. Analyses were performed from the UK National Health Service (NHS) perspective. Uncertainty around inputs and assumptions were explored via scenario and sensitivity analyses, including a cost threshold analysis. Outcomes were cost/quality-adjusted life year (QALY) gained and cost/year gained.Results: Based on our model, the effects of PA in the UK COPD population would be lower mortality (-6%), fewer hospitalizations (-2%), gains in years (+0.82) and QALYs (+0.66), and total cost savings of £2,568. The cost/QALY and cost/year gained were dominant. PA was cost-saving at costs <£35/month and cost-effective at cost <£202/month. The main model drivers were age and PA impact on death and hospital-treated exacerbations.Conclusion: Including PA in the management of COPD leads to long-term clinical benefits. If the NHS promotes only exercise via medical advice, this would lead to health care cost savings. If the NHS chose to fund PA, it would still likely be cost-effective. Keywords: cost-effectiveness, physical activity, exercise, COPD, microsimulation, Markov https://www.dovepress.com/cost-effectiveness-of-physical-activity-in-the-management-of-copd-pati-peer-reviewed-article-COPDCost-effectivenessphysical activityexerciseCOPDmicrosimulationMarkov
spellingShingle Ramos M
Lamotte M
Gerlier L
Svangren P
Miquel-Cases A
Haughney J
Cost-effectiveness of physical activity in the management of COPD patients in the UK
International Journal of COPD
Cost-effectiveness
physical activity
exercise
COPD
microsimulation
Markov
title Cost-effectiveness of physical activity in the management of COPD patients in the UK
title_full Cost-effectiveness of physical activity in the management of COPD patients in the UK
title_fullStr Cost-effectiveness of physical activity in the management of COPD patients in the UK
title_full_unstemmed Cost-effectiveness of physical activity in the management of COPD patients in the UK
title_short Cost-effectiveness of physical activity in the management of COPD patients in the UK
title_sort cost effectiveness of physical activity in the management of copd patients in the uk
topic Cost-effectiveness
physical activity
exercise
COPD
microsimulation
Markov
url https://www.dovepress.com/cost-effectiveness-of-physical-activity-in-the-management-of-copd-pati-peer-reviewed-article-COPD
work_keys_str_mv AT ramosm costeffectivenessofphysicalactivityinthemanagementofcopdpatientsintheuk
AT lamottem costeffectivenessofphysicalactivityinthemanagementofcopdpatientsintheuk
AT gerlierl costeffectivenessofphysicalactivityinthemanagementofcopdpatientsintheuk
AT svangrenp costeffectivenessofphysicalactivityinthemanagementofcopdpatientsintheuk
AT miquelcasesa costeffectivenessofphysicalactivityinthemanagementofcopdpatientsintheuk
AT haughneyj costeffectivenessofphysicalactivityinthemanagementofcopdpatientsintheuk